| Product Code: ETC6768174 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Colombia saw significant import shipments of live biotherapeutic products and microbiome services from top exporting countries including South Korea, China, Germany, United Kingdom, and the United States of America. Despite a high Herfindahl-Hirschman Index (HHI) indicating market concentration, the industry experienced a negative compound annual growth rate (CAGR) of -6.0% from 2020 to 2024. Furthermore, the growth rate in 2024 declined sharply by -48.46%, reflecting potential challenges or shifts in the market dynamics for these products and services in Colombia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Overview |
3.1 Colombia Country Macro Economic Indicators |
3.2 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Colombia Live Biotherapeutic Products And Microbiome CDMO Market - Industry Life Cycle |
3.4 Colombia Live Biotherapeutic Products And Microbiome CDMO Market - Porter's Five Forces |
3.5 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of live biotherapeutic products and microbiome therapies in Colombia |
4.2.2 Growing investments in research and development in the field of microbiome-based therapies |
4.2.3 Favorable regulatory environment supporting the development and commercialization of live biotherapeutic products |
4.3 Market Restraints |
4.3.1 Limited availability of skilled workforce specialized in microbiome research and development |
4.3.2 High costs associated with the development and manufacturing of live biotherapeutic products |
4.3.3 Potential regulatory challenges and uncertainties related to the approval process for microbiome therapies |
5 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Trends |
6 Colombia Live Biotherapeutic Products And Microbiome CDMO Market, By Types |
6.1 Colombia Live Biotherapeutic Products And Microbiome CDMO Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By C.difficle, 2021- 2031F |
6.1.4 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By Crohns disease, 2021- 2031F |
6.1.5 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By IBS, 2021- 2031F |
6.1.6 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.1.7 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Import-Export Trade Statistics |
7.1 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Export to Major Countries |
7.2 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Imports from Major Countries |
8 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Key Performance Indicators |
8.1 Number of clinical trials conducted for live biotherapeutic products in Colombia |
8.2 Percentage of healthcare professionals trained in microbiome-based therapies |
8.3 Level of government support and funding allocated to microbiome research and development in Colombia |
9 Colombia Live Biotherapeutic Products And Microbiome CDMO Market - Opportunity Assessment |
9.1 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Colombia Live Biotherapeutic Products And Microbiome CDMO Market - Competitive Landscape |
10.1 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Revenue Share, By Companies, 2024 |
10.2 Colombia Live Biotherapeutic Products And Microbiome CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |